ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
Lex555
|
279 |
83K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
279
|
83K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
Lex555
|
279 |
83K |
8 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
279
|
83K
|
8
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
Lex555
|
247 |
72K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
247
|
72K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: undetectable PSA level with Cu-67 SAR-bisPSMA
|
|
Lex555
|
62 |
18K |
18 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
62
|
18K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene cGMP API Manufacturing Completed at Laurus Labs
|
|
Lex555
|
74 |
26K |
9 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
74
|
26K
|
9
|
|
ASX - By Stock
|
LTR |
Re:
Lithium Related Media Articles
|
|
Lex555
|
22K |
11M |
1 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
22K
|
11M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
Lex555
|
450 |
145K |
20 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
145K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
Lex555
|
592 |
183K |
15 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
592
|
183K
|
15
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Lex555
|
60 |
33K |
7 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
60
|
33K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial
|
|
Lex555
|
55 |
14K |
1 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
55
|
14K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial
|
|
Lex555
|
55 |
14K |
3 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
55
|
14K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Ceasing to be a substantial holder
|
|
Lex555
|
22 |
5.7K |
4 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
22
|
5.7K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Ceasing to be a substantial holder
|
|
Lex555
|
11 |
4.9K |
0 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
11
|
4.9K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Lex555
|
2.8K |
978K |
9 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
2.8K
|
978K
|
9
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Lex555
|
10K |
3.7M |
2 |
03/05/23 |
03/05/23 |
General
|
10K
|
3.7M
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Voluntary Suspension
|
|
Lex555
|
8 |
3.1K |
3 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
8
|
3.1K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
Lex555
|
54 |
17K |
2 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
54
|
17K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
Lex555
|
239 |
95K |
29 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
239
|
95K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Pause in Trading
|
|
Lex555
|
42 |
12K |
3 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
42
|
12K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
Lex555
|
30 |
8.4K |
7 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
30
|
8.4K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3X - Damian Clarke-Bruce
|
|
Lex555
|
7 |
2.3K |
12 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
7
|
2.3K
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Lex555
|
20K |
6.9M |
15 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
20K
|
6.9M
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Investor presentation for Australian Microcap Conference
|
|
Lex555
|
12 |
5.9K |
14 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
12
|
5.9K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Develops Improved IV Formulation of Zantrene
|
|
Lex555
|
90 |
35K |
16 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
90
|
35K
|
16
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Lex555
|
10K |
4.7M |
9 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
10K
|
4.7M
|
9
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Lex555
|
10K |
4.7M |
2 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
10K
|
4.7M
|
2
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Lex555
|
10K |
4.7M |
0 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
10K
|
4.7M
|
0
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Lex555
|
10K |
4.7M |
35 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
10K
|
4.7M
|
35
|
|
ASX - By Stock
|
BRN |
Re:
Competitive landscape
|
|
Lex555
|
3.8K |
1.4M |
0 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
3.8K
|
1.4M
|
0
|
|
ASX - By Stock
|
BRN |
Re:
Why I've sold all my BRN... and all my other Stocks
|
|
Lex555
|
1.3K |
668K |
14 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
1.3K
|
668K
|
14
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Lex555
|
20K |
6.9M |
5 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
20K
|
6.9M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Lex555
|
20K |
6.9M |
5 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
20K
|
6.9M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage
|
|
Lex555
|
112 |
39K |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
112
|
39K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage
|
|
Lex555
|
112 |
39K |
1 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
112
|
39K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage
|
|
Lex555
|
112 |
39K |
1 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
112
|
39K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Competitive landscape
|
|
Lex555
|
3.8K |
1.4M |
6 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
3.8K
|
1.4M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Announces On-Market Share Buyback
|
|
Lex555
|
215 |
71K |
9 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
215
|
71K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Announces On-Market Share Buyback
|
|
Lex555
|
215 |
71K |
14 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
215
|
71K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: EMD AML MDS Trial Expands to Europe
|
|
Lex555
|
94 |
31K |
18 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
94
|
31K
|
18
|
|
ASX - By Stock
|
BRN |
Re:
Competitive landscape
|
|
Lex555
|
3.8K |
1.4M |
3 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
3.8K
|
1.4M
|
3
|
|
ASX - By Stock
|
IXR |
Re:
Ann: Substantial Increase to Makuutu REE Resource to over 500Mt
|
|
Lex555
|
306 |
154K |
6 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
306
|
154K
|
6
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Change of Director's Interest Notice
|
|
Lex555
|
19 |
6.6K |
2 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
19
|
6.6K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: MD Anderson Preclinical AML Study on Zantrene Published
|
|
Lex555
|
54 |
18K |
52 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
54
|
18K
|
52
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Lex555
|
962 |
291K |
2 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
962
|
291K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Lex555
|
962 |
291K |
1 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
962
|
291K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Why I've sold all my BRN... and all my other Stocks
|
|
Lex555
|
1.3K |
668K |
1 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
1.3K
|
668K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Lex555
|
10K |
4.7M |
13 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
13
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Lex555
|
10K |
3.7M |
7 |
29/01/22 |
29/01/22 |
General
|
10K
|
3.7M
|
7
|
|
ASX - By Stock
|
SPQ |
Re:
Ann: Trading Halt
|
|
Lex555
|
157 |
49K |
1 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
157
|
49K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Lex555
|
315 |
124K |
8 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
315
|
124K
|
8
|
|